ASAKE BIOTECHNOLOGY, LLC
Biotech · Private
Small-molecule therapeutic (MSB-3) for type 1 diabetes that protects beta cells from cytokine-induced death and enhances insulin production
- Grants
- $2.3M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A dual-acting small molecule for the treatment of type 1 diabetes | $299,974 | |
| Federal grant | Department of Health and Human Services · Phase II · A dual-acting small molecule for the treatment of type 1 diabetes | $609,183 | |
| Federal grant | Department of Health and Human Services · Phase II · A dual-acting small molecule for the treatment of type 1 diabetes | $740,897 | |
| Federal grant | Department of Health and Human Services · Phase II · A dual-acting small molecule for the treatment of type 1 diabetes | $625,501 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1747 | Airway Therapeutics, LLC | — | $54M |
| 1748 | Quoin Pharmaceuticals, Ltd. | — | $164M |
| 1749 | Tempo Therapeutics Inc | — | $34M |
| 1750 | ASAKE BIOTECHNOLOGY, LLC | — | — |
| 1751 | ANTHROBIO, INC. | — | — |
| 1752 | Torque Medical Holdings, LLC | — | $4.7M |
| 1753 | Navitor Pharmaceuticals | — | $65M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.